Gene · 10765
Papers2,218
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,218
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumour cell-derived serglycin promotes IL-8 secretion of CAFs in gastric cancer. | Br J Cancer | 2024 | 38862740 | PubTator, text mining | PubMed |
| LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B. | J Cancer Res Clin Oncol | 2024 | 38842683 | PubTator, text mining | PubMed |
| Establishment and validation of a gene mutation-based risk model for predicting prognosis and therapy response in acute myeloid leukemia. | Heliyon | 2024 | 38831838 | PubTator, text mining | PubMed |
| KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma. | Cell Death Discov | 2024 | 38789418 | PubTator, text mining | PubMed |
| KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges. | Mol Cancer | 2024 | 38769556 | PubTator, text mining | PubMed |
| Transcription factor AP-2 gamma affects porcine early embryo development by regulating epigenetic modification. | Reprod Biomed Online | 2024 | 38749801 | PubTator, text mining | PubMed |
| Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer. | Eur J Med Chem | 2024 | 38749268 | PubTator, text mining | PubMed |
| Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis. | Prostate | 2024 | 38605532 | PubTator, text mining | PubMed |
| The Intellectual Disability Risk Gene Kdm5b Regulates Long-Term Memory Consolidation in the Hippocampus. | J Neurosci | 2024 | 38575342 | PubTator, text mining | PubMed |
| Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy. | Nat Genet | 2024 | 38553553 | PubTator, text mining | PubMed |
| DLX3 (Q178R) mutation delays osteogenic differentiation via H19/miR-29c-3p/KDM5B axis in TDO-iPSCs-derived MSCs. | Genes Dis | 2024 | 38481875 | PubTator, text mining | PubMed |
| The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence. | Exp Cell Res | 2024 | 38462208 | PubTator, text mining | PubMed |
| Rare-variant collapsing and bioinformatic analyses for different types of cardiac arrhythmias in the UK Biobank reveal novel susceptibility loci and candidate amyloid-forming proteins. | Cardiovasc Digit Health J | 2024 | 38390584 | PubTator, text mining | PubMed |
| KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck. | Mol Carcinog | 2024 | 38353298 | PubTator, text mining | PubMed |
| The Dynamics of Histone Modifications during Mammalian Zygotic Genome Activation. | Int J Mol Sci | 2024 | 38338738 | PubTator, text mining | PubMed |
| Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis. | RNA | 2024 | 38296629 | PubTator, text mining | PubMed |
| Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma. | Cell Commun Signal | 2024 | 38291473 | PubTator, text mining | PubMed |
| Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer. | Cell Rep Med | 2024 | 38290515 | PubTator, text mining | PubMed |
| Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis. | Cell Death Differ | 2024 | 38287116 | PubTator, text mining | PubMed |
| A Pregnancy and Childhood Epigenetics Consortium (PACE) meta-analysis highlights potential relationships between birth order and neonatal blood DNA methylation. | Commun Biol | 2024 | 38195839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10765/papers?page=7